misc Flashcards
P450 inducers
Inducible Momma Barb Steals Phen-phen and refuses Greasy Carbs Chronically
Modafinil Barbiturates St John's Wort Phenytoin Rifampin Griseofulvin Carbamazepine Chronic alcohol
P450 inhibitiors
MAGIC RACKS in GQ Macrolides Amiodarone GFJ INH Cimetidine Ritonavir Acute Alcohol Ciprofloxacin Ketoconazole Sulfonamides (TMP/SMX) Gemfibrozil Quinidine
Sulfa Drugs
Popular FACTSSS Probenecid Furosemide Acetazolamide Celecoxib Thiazides Sulfonamide Sulfasalazine Sulfonylureas
Allergy = fever, UTI, pruritic rash, SJS, hemolysis, thrombocytopenia, agranulocytosis, urticaria
cAMP hormones
FLAT ChAMP
FSH, LH, ACTH, TSH, CRH, hCG, ADH (V2), MSH, PTH
cGMP hormones
vasodilators: ANP, NO
IP3 hormones
GGGOAT
GnRH, GHRH, Gastrin, Oxytocin, ADH (V1), TRH
Steroid hormones
Vitamin D, EStrogen, Testosterone, T3/T4, Cortisol, Aldosterone, Progesterone
Intrinsic Tyrosine kinase hormones
MAP kinase –> Ras
Growth factors: Insulin, IGF-1, FGF, PDGF, EGF
Receptor -associated tyrosine kinase
JAK/STAT pathway
PIG: Prolactin, Immunomodulators (cytokines, IL-2,6,8, IFN), GH
Path vit D def
osteomalacia
failure to mineralize (Ca) osteoid matrix (made by osteoblasts)
increased deposition of unmineralized osteoid matrix around trabeculae
Path Paget dz
disorganized lamellar bone in mosaic pattern with cement lines
Path osteopetrosis (marble bone dz)
persistence of primary spongiosa in medullary cavity with no mature trabeculae. Osteoclastic dysfunction→ accumulation of woven bone and diffuse bone thickening
Bones in CKD
osteitis fibrosa cystica (from PTH)
osteomalacia (from lack of Vit D)
osteoporosis (from hypoCa)
path osteoporosis
leaching of calcium from bones slowly over time
trabecullar thinning with fewer interconnections
path hyperPTH
osteitis fibrosa cystica
Resorption of bone Ca → “burn out” → fibrosis and cysts
subperiosteal thinning → erosions and salt and pepper skull
Efficacy
Emax
Potency
dose requirement (ED50)
Drug-induced lupus
slow acetylators
Hydral
Procainamide
INH
Effect of competitive antagonist on dose-response curve
shifts curve to right (ED50 incr), without affecting Emax
effect of noncompetitive or irreversible antagonist on dose-response curbe
does not shift curve, reduces Emax
MEN syndromes
Men 1 – 3Ps. parathyroid, Pancreatic (ZES), pituitary adenoma (PRL, ACTH)
Men 2a 1M, 2 Ps: Medullary thyroid (calcitonin), pheo, parathyroid
Men 2b: 3Ms, 1 P: Medullary, Marfanoid, Mucosal neuromas, pheo
actions of TGFb
- arrest of cell cycle (tumor suppressor)
- promotes angiogenesis (allows mets to survive once they become resistant to it)
- stimulates fibroblasts to lay down ECM proteins (role in atherosclerosis and fibrosis
action of bradykinin
secreted by kidney when RAAS activated. constricts veins and dilates arterioles locally to incr renal perfusion
BNP and ANP pathways
increase cGMP –> vasodilation. Also cause natruresis
skeletal muscle excitation- contraction coupling
depolarization –> opening of L-type Ca Channels –> direct opening through physical interaction of RyR1 Ca channels on SR –> release of Ca –> Troponin C
NO extracellular Ca flux. no effect of CCBs
cardiac muscle E-C coupling
L type channel –> Calcium influx –> binding to RyR2 (Ca-dependent Ca release) –> troponin C
Smooth muscle E-C coupling
L type channel –> Ca influx –> RyR (Ca-dependent Ca release) –> calmodulin –> Myosin LC kinase –> myosin phosphorylation –> actin binding –> muscle contraction